Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) FCF Margin (2016 - 2025)

CorMedix (CRMD) has disclosed FCF Margin for 12 consecutive years, with 72.11% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 9013.0% to 72.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 55.43% through Dec 2025, up 17216.0% year-over-year, with the annual reading at 55.43% for FY2025, 17213.0% up from the prior year.
  • FCF Margin hit 72.11% in Q4 2025 for CorMedix, up from 29.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 176630.4% in Q1 2024 to a low of 89069.3% in Q3 2022.
  • Historically, FCF Margin has averaged 246.72% across 5 years, with a median of 1745.98% in 2024.
  • Biggest five-year swings in FCF Margin: surged 20698320bps in 2023 and later tumbled -17657993bps in 2025.
  • Year by year, FCF Margin stood at 11522.1% in 2021, then tumbled by -84bps to 21155.46% in 2022, then soared by 661bps to 118603.6% in 2023, then crashed by -100bps to 18.02% in 2024, then surged by 500bps to 72.11% in 2025.
  • Business Quant data shows FCF Margin for CRMD at 72.11% in Q4 2025, 29.11% in Q3 2025, and 75.42% in Q2 2025.